Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

Blog - Biotechnology
Dec 2025
USPTO’s Automated Search Pilot: Through a Biotech Lens
In October 2025, the U.S. Patent and Trademark Office (USPTO) launched the “Artificial Intelligence Search Automated Pilot Program,” or ASAP!, an initiative to identify potential prior art using artificial intelligence...
Publications
Dec 2025
Bryan McWhorter Authors Legaltech News Article on How Generative AI Is Transforming Patent Prosecution
In the Legaltech News article “Reports of Death Greatly Exaggerated: Why Generative AI Is Powering, Not Pulverizing, Patent Prosecution,” Knobbe Martens partner Bryan McWhorter explores the impact of generative AI...
Publications
Nov 2025
Jeremiah Helm and Sean Murray’s Discuss Extension of Printed Matter Doctrine in Law360 Column
In their latest Law360 column discussing noteworthy Federal Circuit cases, partners Jeremiah Helm and Sean Murray examine the recent decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., and how...